SightfileU.S. market data from official filings
Companies › XRTX
XORTX THERAPEUTICS INC (XRTX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001729214 · EDGAR filings · Updated 2026-06-15
XORTX THERAPEUTICS INC (XRTX) has 2 institutional managers reporting positions valued at $6.23K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Institutional managers
2
Reported 13F value
$6.23K
Data flags
1 active
from SEC filings
Latest updates
- 2026-06-15 — Foreign issuer report (6-K) filed
- 2026-06-12 — Foreign issuer report (6-K) filed
- 2026-05-19 — Foreign issuer report (6-K) filed
- 2026-05-19 — Foreign issuer report (6-K) filed
- 2026-05-15 — Prospectus supplement (424B4) filed
- 2026-05-14 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, XORTX THERAPEUTICS INC has 2 institutional holders.
Data flags from SEC filings
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-20 (recurring since 2025-05-12) — source filing. The authoritative details are those stated in the filing itself.
Related companies
United Health Prods Inc COM (UEEC) · CLEARSIDE BIOMEDICAL INC (CLSDQ) · NUO THERAPEUTICS INC (AURX) · VIREO GROWTH INC (VREOF) · Kaya Holdings, Inc. (KAYS) · PREMIER AIR CHARTER HOLDINGS INC (PREM)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.